Navigation Links
Cardiatis Multilayer Aneurysm Repair System, MARS, Receives CE Mark Approval for Treating Peripheral Aneurysms
Date:6/9/2009

Cardiatis SA, today announced that its Multilayer Aneurysm Repair System (MARS) has received CE Mark approval for treating patients with peripheral aneurysms. Product rollout is underway.

Brussels, Belgium (PRWEB) June 9, 2009 -- Cardiatis, SA announced today that it has received CE Mark approval for the commercial sale of its Multilayer Aneurysm Repair System.

The Multilayer Aneurysm Repair System (MARS) is based on non-invasive paradigm shifting technology that treats aneurysms, regardless of their location, endovasculary through hemodynamic flow modulation and parent artery repair techniques. The received CE Mark is for the peripheral indication and clinical development is underway for cerebral and thoraco-abdominal aortic aneurysm indications.

Due to novelty of the technology, Cardiatis has initiated limited rollout of the product to select interventional centers where physician training is underway.

"We are very pleased to provide physicians and patients with Cardiatis breakthrough Multilayer Aneurysm Repair System", said Noureddine Frid, Cardiatis president and chief executive officer. "Physicians will now have access to a new minimally-invasive technology that will allow them to treat peripheral aneurysms endovasculary while preserving precious collateral circulation."

The Multilayer Aneurysm Repair System (MARS) has proven to be highly deliverable and is effective in excluding aneurysms from circulation while preserving collaterals. It also offers an excellent safety profile, which is important to both physicians and patients.

More than 95% of peripheral artery aneurysms occur in males, and the average age of patients at presentation is 65 years. Atherosclerosis appears to be the etiology in more than 90% of cases. Popliteal artery aneurysms are the most common peripheral artery aneurysms accounting for up to 85% of total aneurysms in the periphery.

About Cardiatis

Cardiatis, an innovative medical technology company located in Belgium, is focused on developing and commercializing its patented Multilayer technology platform, a next generation technology for endovascular aneurysm repair. Additional information can be found on Cardiatis web site at www.cardiatis.com.

###

Read the full story at http://www.prweb.com/releases/Endovascular/Aneurysm/prweb2507714.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Too Few Screened for Abdominal Aneurysm, Study Says
2. NeuroVasx Receives CE Mark for cPAX Aneurysm Treatment System
3. Less Invasive Interventional Treatment Can Be Recommended as First-Line Treatment for Silent Killer, Abdominal Aortic Aneurysm
4. Verathon(R) Introduces BladderScan(R) BVI 9600 Bladder Volume Instrument with AortaScan(TM) Mode to Help Physicians Identify the Presence of Abdominal Aortic Aneurysms
5. Aneurysms in 2nd Generation May Not Come Early
6. Routine testing after aneurysm coiling carries low risk
7. Brain Aneurysm Rupture Risk Tied to Location, Size
8. The Brain Aneurysm Foundation Announces 2008 Research Grant Recipients
9. NYC first: Complex aneurysm treated using new fenestrated endograft stent
10. Carnegie Mellon researchers improve assessments of aortic aneurysms
11. Women, Mexican-Americans at higher risk of ruptured brain aneurysm
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cardiatis Multilayer Aneurysm Repair System, MARS, Receives CE Mark Approval for Treating Peripheral Aneurysms
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... Nevada (PRWEB) , ... June 24, 2016 , ... ... Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations ... in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Consumers have taken ... regulators/payers have placed more emphasis on patient outcomes. ... support programs in the pharmaceutical industry have evolved ... Consequently, pharmaceutical companies are focusing on becoming more ... providing products and services that improve health. ...
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
(Date:6/24/2016)... , June 24, 2016 ... has announced the addition of the " Global ... This report ... provides an updated review, including its applications in various ... total market, which includes three main industries: pharmaceutical and ...
Breaking Medicine Technology: